Ann Arbor · Pre-Seed–Series A · 29 people tracked
Also known as ARBORETUM VENTURES, LLC
Find your way into Arboretum Ventures
1,315 people in our graph share verified history with the Arboretum Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Arboretum Ventures pursues a strategy of investing in under-ventured geographies and sectors within healthcare, emphasizing deep relationships with entrepreneurs, executives, and investment partners across the industry. The firm targets early-stage healthcare startups that solve large healthcare problems and can deliver transformational impact, backing teams that are diverse in thought, geography, and demographics. It focuses on medical devices, life science tools and diagnostics, tech-enabled care delivery, and pharma adjacencies, aiming to identify companies that create value in a capital-efficient manner, accelerate portfolio value, and generate superior returns while positively impacting patients and communities.
Source: firm website, verified Sep 15, 2026.
Team · 29 people
from the firm's website & public directories
Founder mafia
2 people who came through Arboretum Ventures went on to found or lead other companies.
What they invest in
from 43 of 63 portfolio companiesHealthtech ×33Medical Devices ×27Biotech ×18Digital Health ×15Hardware ×9Deep Tech ×7AI & Machine Learning ×5Advanced Manufacturing ×2
HQs:United States×43
Who they back
founder profiles across 21 portfolio companiesFounding team size:solo founder×172 founders×33 founders×1
Investments · showing 59 of 63
founders shown can be your intro pathBy year:2026 · 32025 · 32024 · 22022 · 22021 · 32020 · 22019 · 12018 · 22016 · 32015 · 42014 · 126 dated
Shoulder Innovations develops InSet® glenoid technology for shoulder joint implants that reduce the rocking horse effect and provide mechanical stability, serving patients with severe shoulder arthritis.
HardwareHealthtechMedical DevicesNorthern California, US
Robert Ball(CEO & Executive Chairman)Matthew Ahearn(Chief Operating Officer)inJeff Points(Executive Officer)inDavid Blue(Executive Officer)inDon Running(Manager and Chief Executive Officer)Jeff Ondrla(Chief Technology Officer)
Co-investorsAPERTURE Venture PartnersGenesis Innovation GroupGlobal BrainInvest MichiganLightstone VenturesUS Venture Partners+2 more
SI-BONE develops medical devices for treating sacroiliac (SI) joint dysfunction and chronic low back pain, targeting patients and physicians.
HealthtechMedical DevicesSan Jose, US
Mark Reiley(Director)inJeffrey W. Dunn(Executive Officer, Director)Robert E. Johnson(Executive Officer)Dan Murray(Executive Officer)Laura A. Francis(Chief Executive Officer)
BoardTimothy E. Davis(Director)
PartnerTim Petersen· led
Co-investorsMontreux Equity PartnersOrbiMed
Convergent Dental is a privately owned dental equipment and technology company whose flagship product, Solea, is a CO2 all-tissue laser cleared by the FDA that offers anesthesia-free, blood-free, and suture-free dental procedures.
Enterprise SoftwareHardwareHealthtechMedical DevicesNatick, US
Nathan P. Monty(Executive Officer, Director)inMichael J. Cataldo(Executive Officer, Director)Rob Gershon(Chief Executive Officer)inMark Collins(Chief Financial Officer)inTodd Hornsby(Chief Commercial Officer)in
BoardBart Doedens(Director)
Board seatTimothy PetersenTimothy B. Petersen· per SEC Form D
Co-investorsLRVHealthTrinity Capital
Boomerang Medical develops a bioelectric neuromodulation device to treat bowel urgency symptoms in patients with ulcerative colitis and other inflammatory bowel disease.
BiotechDigital HealthMedical DevicesMountain View, US
Co-investorsHatteras Venture Partners
Orasis is a pharmaceutical company developing drugs for the eye, operating in the ophthalmology and eyecare space.
BiotechHealthtechMedical Devices
Co-investorsMaverick Ventures IsraelVisionary VenturesCatalio Capital ManagementJohnson & Johnson Innovation – JJDCLifeSci Venture PartnersSequoia Capital+1 more
PAK BioSolutions builds automated systems and single-use flow kits for end-to-end continuous purification of biopharmaceuticals, running four continuous purification stages simultaneously for a stated 4X productivity gain over batch methods.
Advanced ManufacturingBiotechHardwareBurke, US
Pezzini Joanna(President)inKevin Hill-Byrne(Co-Founder & CTO)in
HealthtechSt Louis, US
Andrea M. Clegg(Executive Officer)Louis Silverman(Executive Officer, Director)
BoardBarbara Lubash(Director)inMichael Mikolajczyk(Director)David N. Schopp(Director)
Board seatTimothy B. Petersen· per SEC Form D · $7.3M raise · filed Jul 2015
Co-investorsVersant Ventures
Allay Therapeutics develops localized pain management technology designed to deliver several weeks of post-surgical pain relief.
BiotechHealthtechMedical DevicesSan Jose, US
Adam Gridley(Executive Officer, Director)inKristen Howells(Executive Officer)inJosh Makower(Director)Tak Cheung(Director)inKarun D. Naga(Executive Officer, Director)
BoardLeighton Read(Director)
Board seatPaul McCreadie· per SEC Form D
Co-investorsLightstone VenturesNew Enterprise Associates (NEA)SGInnovateClavystBio
ArborMetrix provides a software platform for healthcare quality improvement that aggregates and analyzes patient data to help providers, payers, and health systems optimize clinical and financial performance, reduce adverse events, and improve outcomes.
Data & InfrastructureEnterprise SoftwareHealthtechAnn Arbor, US
John Birkmeyer, M.D.(Director)Brett Furst(Executive Officer, Director)inChristian Birkmeyer(Executive Officer)Steven Richvalsky(Executive Officer)
BoardPaul McCreadie(Director)inAnthony Grover(Director)
Board seatTimothy Petersen· per SEC Form D
Co-investorsID Ventures
Francis Medical is a medical device company developing minimally invasive urological cancer treatments using water vapor ablation technology, initially focused on prostate cancer with its Vanquish Water Vapor Ablation System.
BiotechDigital HealthHealthtechMedical DevicesMaple Grove, US
Michael Hoey(Founder)inMichael Kujak(Executive Officer, Director)Christopher Dixon(Chief Medical Officer)in
BoardAndrew Cleeland(Director)David Adair(Director)in
Board seatJan Garfinkle· per SEC Form D
Co-investorsSolas BioVentures
Health Scholars (UpSkillAI) provides AI- and XR-based immersive training, using voice-powered VR simulations that let teams practice protocols hands-free.
AI & Machine LearningEdTechFuture of WorkWestminster, US
BRIAN GILLETT(Executive Officer)ROBERT SEHRING(Director)ANGELA MCFARLAND(Executive Officer)SCOTT JOHNSON(Executive Officer, Director)LAURA MEDINA(Executive Officer)RIKARD STEIBER(Director)
Board seatThomas Shehab· per SEC Form D
Co-investorsCapital Midwest FundService Provider CapitalClarevia VenturesVenture Investors Health Limited Partnership
Koya Medical develops wearable compression therapy devices, including its Dayspring system, for treating conditions such as lymphedema, chronic venous insufficiency, and deep vein thrombosis.
HardwareHealthtechMedical DevicesOakland, US
Anand Doraiswamy(Executive Officer, Director)in
BoardJosh Baltzell(Director)in
Board seatJan Garfinkle· per SEC Form D
Co-investorsAphelion CapitalScientific Health DevelopmentZühlke VenturesCadence Healthcare VenturesOrbiMed
Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.
BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US
Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)in
BoardJacob Robinson(Co-founder & CEO)in
Board seatThomas M. Shehab· per SEC Form D
Co-investorsPsyMed VenturesTMC Venture FundXEIA Venture PartnersCapital FactoryDivergent CapitalDolby Family Ventures+3 more
Seattle, US
Ronald Seubert(Executive Officer, Director, Promoter)Evan Castiglia(Executive Officer)inJoseph Victor(Executive Officer, Director)Frank Witney(Director)Eric Kaldjian(Executive Officer)
BoardRobert Shepler(Director)in
Board seatJan Garfinkle· per SEC Form D
Co-investors5AM VenturesF-Prime CapitalSofinnova VenturesTelegraph Hill Partners
Reprieve Cardiovascular develops a decongestion management system that uses real-time patient data to guide and personalize diuretic therapy for fluid removal in heart failure patients.
Digital HealthHealthtechMedical DevicesMilford, US
Tony Fields(Executive Officer)Adam Bartnik(Executive Officer)inMark Pacyna(Executive Officer, Director)inJim Dillon(Executive Officer, Director)Hanson S. Gifford III(Director)Gregory W Mann(Executive Officer)
Board seatJan Garfinkle· per SEC Form D
Co-investorsLightstone VenturesRex Health VenturesDeerfield Management CompanyGenesis Venture CapitalSante Ventures
Strata Oncology develops precision oncology biomarkers and predictive diagnostic tools for cancer treatment, including treatment response scores for antibody-drug conjugates (ADCs) and an Immunotherapy Response Score for anti-PD-1/PD-L1 therapies.
AI & Machine LearningBiotechDigital HealthMedical DevicesAnn Arbor, US
Daniel Rhodes(Executive Officer, Director)Matthew Martin(Executive Officer)Jeffrey Williams(Executive Officer, Director)
BoardChristopher O'Donnell(Director)inDavid Rubin(Director)inJames Pavlik(Director)in
Board seatJan GarfinkleNicole Walker· per SEC Form D
Co-investorsPfizer Venture InvestmentsDeerfield Management CompanyMerck Global Health Innovation FundPfizer Ventures
SonarMD provides a care management platform for chronic diseases, starting with gastroenterology, that combines AI technology with human support to detect clinical deterioration early and help specialists intervene before emergencies.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSaaSChicago, US
Lawrence R. Kosinski(Founder and Board Member)inBETH HOUCK(Executive Officer, Director)inJohn Starr(Executive Officer)Devin Gross(Executive Officer, Director)
Board seatCharity TarnThomas M ShehabTom Shehab· per SEC Form D
Co-investorsBlue Hour VenturesHypothesisNueterra CapitalTensility Venture PartnersBlueCross BlueShield Venture Partners
Virtual Incision develops a miniaturized robotic-assisted surgery (miniRAS) system called MIRA, designed to fit within hospitals' existing infrastructure.
BiotechHealthtechMedical DevicesRoboticsLincoln, US
Dmitry Oleynikov(Director)Shane Farritor(Executive Officer, Director)John P. Murphy(Executive Officer, Director)inMukund Srinivasan(Executive Officer)in
BoardFred Robertson(Director)
Board seatTom Shehab· per SEC Form D
Co-investorsEndeavour VisionInvest NebraskaInVivium CapitalBaird CapitalPrairieGold Venture Partners
Akadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products.
Advanced ManufacturingBiotechDeep TechHealthtechMedical DevicesAnn Arbor, US
Kalyan Handique(Executive Officer, Director)John Younger(Executive Officer, Director)inJames Militello(Executive Officer)
BoardJeffrey S. Williams(Director)Paul D'Amato(Director)inDan Kidle(Director)in
Co-investorsBeringeaBerkeley CatalystBlueStone Venture PartnerseLab VenturesID VenturesInvest Michigan+5 more
AtaCor Medical develops extravascular lead systems for cardiac rhythm management, including a novel extravascular defibrillation lead for EV-ICD therapy and an implantable, extracardiac pacemaker.
HardwareHealthtechMedical Devices
Alan(Co-founder & Vice President of Clinical, Regulatory & Quality)
Co-investorsBayMed Venture PartnersBroadview VenturesCatalyst Health VenturesHatteras Venture Partners
Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions.
Digital HealthHealthtechMedical DevicesValencia, US
Manish Vaishya, PhD(Chief Executive Officer, Co-Founder & Board Member)Jill Schiaparelli(Executive Officer, Director)inKevin Wasserstein(Director)
BoardThomas Shehab, MD(Director)
Co-investorsAngelini VenturesShangBay Capital LLCAvestria Ventures
Non-surgical, non-pharmacologic devices to induce weight loss
Co-investorsDelos CapitalLongitude CapitalHighland Capital PartnersSante Ventures
Digital HealthHealthtechMedical DevicesSanta Barbara, US
Justin Bellante(Executive Officer, Director, Promoter)Brent Peus(Executive Officer)
BoardBrandon Cady(Director)Jeff Closs(Director)Patrick Cua(Director)Kathleen Shanahan(Director)
PartnerPaul McCreadie· led
Co-investorsHealthQuest Capital
BrightSpec develops molecular rotational resonance (MRR) spectroscopy instruments and software that identify and quantify gas-phase molecules from complex mixtures without front-end separation.
BiotechDeep TechHardwareWaltham, US
Rick Gordon(CEO)inWalter Colsman(Executive Officer, Director)JAFFRAY WOODRIFF(Director)ROBERT LLOYD(Executive Officer, Director)THOMAS JONES(Director)DAVID MCDANIEL(Executive Officer, Director)
Co-investorsGenoa VenturesMedvest Capital
ConcertoCare provides coordinated in-home and center-based medical, behavioral, and social care for seniors and adults with complex care needs who have Medicare, Medicare Advantage, or Medicare+Medicaid coverage.
Digital HealthHealthtechLongevity
Co-investorsAtento CapitalObvious VenturesSteelSky VenturesAddeparDeerfield Management CompanyVast Ventures+1 more
Endogenex is a clinical-stage medical device company developing the pulsENDO system, which applies non-thermal pulsed electric field to reset the body's metabolic signaling and improve function in people with type 2 diabetes.
Digital HealthHealthtechMedical DevicesMinneapolis, US
Stacey Pugh(Leadership (CEO))inChris Sorli, MD, PhD(Chief Medical Officer)inKrissy Wright(Chief Financial Officer)inLian Cunningham, MD, PhD(VP Clinical Affairs)inMelanie Hess(Regulatory Affairs Leadership)inMatt Cambronne(Technical/Engineering Leadership)in
Co-investorsIntuitive VenturesLongitude CapitalLumira Ventures
Enumera Molecular develops technology and a platform for simplified, lower-cost workflows that enable liquid biopsy and high-dimensional omics assays for laboratories.
BiotechDeep TechHealthtechMedical DevicesAnn Arbor, US
Matthew Cooper(CEO & Co-founder)inElaine Heron(Director)
EQRx was a Cambridge, MA biopharma that aimed to sell lower-priced novel drugs; it was acquired by Revolution Medicines in 2023.
Co-investorsAndreessen HorowitzARCH Venture PartnersGV (Google Ventures)Bain Capital
BiotechAnn Arbor, US
Antonio M. Gotto, Jr.(Director)Tim M. Mayleben(Executive Officer, Director)Gilbert S. Omenn(Director)Daniel Janney(Director)Dov A. Goldstein(Director)Roger S. Newton(Director)
Co-investorsAisling CapitalAlta PartnersARCHIMED JapanAsset Management CompanyCanaan PartnersLongitude Capital+2 more
Software that detects subtle vital-sign changes to warn medical professionals of post-operative patient deterioration risk.
Jen Baird, NACD.DC(Founder)inMark Salamango(Founder)in
Co-investorsInvest MichiganWMU Biosciences Research & Commercialization CenterCultivation Capital
Flosonics Medical makes FloPatch, a wireless wearable Doppler ultrasound device that assesses a patient's carotid arterial pulse in real time to give clinicians hemodynamic data for fluid resuscitation decisions.
Digital HealthHardwareMedical Devices
Joe Eibl(Founder)in
Co-investorsAmplify CapitalGenesys CapitaliGan PartnersNew Leaf Venture PartnersRBCx
Hicuity Health is an independent provider of acute and critical care telemedicine services, including tele-ICU, in-patient telemetry monitoring, virtual nursing, virtual sitter, and smart device monitoring.
Digital HealthHealthtechMedical DevicesSt. Louis, US
Isabelle Kopec(Co-founder)Lou Silverman(Chairman & CEO)inAndrea Clegg(CFO & Compliance Officer)inJason Kressel(Chief Operating Officer)inSergio Piñon(Head of Enterprise Clinical Applications)inCorey Danko(Head of IT Infrastructure)in
PartnerTim Petersen· led
Co-investorsCorewell Health Ventures
Inogen is a global medical technology company that develops, manufactures, and markets portable oxygen concentrators and other respiratory therapy devices for home use.
Digital HealthHardwareHealthtechMedical Devices
Ali Bauerlein(Founder)in
Jumpcode Genomics develops CRISPRclean, a next-generation sequencing technology that removes abundant, uninformative sequences to improve sensitivity, lower costs, and simplify workflows for researchers.
AI & Machine LearningBiotechDeep TechHealthtechSan Diego, US
David Michael Salter(Executive Officer, Director)Mike Salter(CEO/President)inEugene Chen(Director)Keith Brown(Executive Officer, Director)Joel Rotroff(Director)
BoardCourt Turner(Director)
Co-investorsLYZZ Capital
Nashville, US
Lance Fusacchia(Executive Officer)inThomas Cox(Executive Officer, Director)Susan Brownie(Executive Officer)in
BoardJay C. Mason(Director)Timothy Petersen(Director)David Jones, Jr.(Director)in
Co-investorsChrysalis Ventures
Pharaoh Neuro is a neurotechnology company focused on protecting and restoring brain health, with an emphasis on the fluids surrounding the brain such as cerebrospinal fluid.
BiotechDeep TechHealthtechMedical Devices
Mark Wagner(Founder, Investor, & Director in Pharaoh)inDr. Nandan Lad(Chief Medical Officer & Co-Founder)Rich Nazarian(Founder, Investor, & Director in Pharaoh)inAmaza Reitmeier(Chief Executive Officer, Director)in
Co-investorsHatteras Venture PartnersIAG Capital PartnersLaerdal Million Lives Fund
Uptake Medical is a medical device company developing Bronchoscopic Thermal Vapor Ablation, a non-surgical, non-implant therapy that applies heated water vapor to ablate diseased lung tissue.
BiotechHealthtechMedical DevicesTustin, US
Robert Barry(Executive Officer, Promoter)Krista Mann(Executive Officer)R. King Nelson(Executive Officer, Director)in
BoardCarl Simpson(Director)David Singer(Director)inGeoff Brooke(Director)
Co-investorsMaverick Ventures
ViaLase develops the ViaLase Laser System, a femtosecond laser and HD imaging platform for noninvasive interventional glaucoma treatment that creates apertures through the trabecular meshwork in patients with open-angle glaucoma.
Deep TechHealthtechMedical DevicesAliso Viejo, US
Tibor Juhasz(Executive Officer, Director)inRick Lewis(Executive Officer)Scott Cooper(Executive Officer)Hadi Srass(Executive Officer)inShawn O'Neil(Executive Officer)in
BoardWilliam Link(Director)
Co-investorsVersant Venture AIV Holdings
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CervilenzConcerto HealthcareNxthera IncPear TherapeuticsTangent Medical TechnologiesTrove AnalyticsAccuri CytometersAtacorCardioMEMSDelphinus Medical TechnologiesDropworksHandyLabHealthMediaIntelliCytLucina HealthNeuMoDx MolecularNvision MedicalReprieve MedicalRethinkSwift BiosciencesVasoNova
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 6
2 IPOs · 4 acquisitions · showing 3Shoulder InnovationsNYSE: SISI-BONENASDAQ: SIBNBioIQacq. by LetsGetChecked
Portfolio news
latest coverage across their companiesHicuity Health · 01net.it · Aug 17, 2026
Inogen · tradingview.com · Aug 11, 2026
SI-BONE · biospace.com · Aug 4, 2026
Pharaoh Neuro · arboretumvc.com · Jul 27, 2026
Shoulder Innovations · investing.com · Jun 29, 2026
Convergent Dental · startupfundraising.com · Jun 17, 2026
Koya Medical · briefglance.com · May 26, 2026
IPO stake values · per SEC filings · 2
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| SI-BONE | 7.4% | $15.00 | Oct 2018 | $25.4M |
| Shoulder Innovations | 4.9% | $15.00 | Aug 2025 | $15M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- How many investments has Arboretum Ventures made?
- Arboretum Ventures has 63 tracked investments, 6 of which have exited, including 6 dated in the last 24 months.
- What stage does Arboretum Ventures invest at?
- Arboretum Ventures invests at the Pre-Seed, Seed, Series A stages.
- What is Arboretum Ventures's typical check size?
- Arboretum Ventures typically writes checks of $5M – $15M.
- What sectors does Arboretum Ventures focus on?
- Arboretum Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Arboretum Ventures located?
- Arboretum Ventures is headquartered in Ann Arbor, US.
- Does Arboretum Ventures lead rounds?
- Yes, Arboretum Ventures leads investment rounds.
- Who does Arboretum Ventures co-invest with?
- Arboretum Ventures most often shares deals with Hatteras Venture Partners, Lightstone Ventures, F-Prime Capital, among 69 tracked co-investors.
From the blog
visit blog ↗Arboretum Ventures recently highlighted clinical milestones at its portfolio companies, including full enrollment completion at diabetes device firm Endogenex and first patient enrollment at cardiac rhythm management company AtaCor Medical. AI summary
Media · Podcasts & interviews
featuring the teamJan Garfinkle – Arboretum Ventures (Manager Meetings, EP.09)
Capital Allocators with Ted Seides · Jan Garfinkle
Co-investors · 33
Hatteras Venture Partners is a venture capital firm focused on early-stage life sciences and healthcare companies, backing therapeutics, diagnostics, and businesses aiming to transform healthcare delivery and innovation.
Lightstone Ventures is a life sciences venture firm founded in 2012 that invests in biotech and medtech companies, backing founders translating scientific breakthroughs into therapies and medical technologies.
F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.
Santé is a healthcare-focused investment firm that manages over $1 billion across venture and public-market strategies. Through Santé Ventures it backs private healthcare startups, and through Santé Capital it runs a liquid hedge fund strategy using proprietary data-science software.
Beringea is a transatlantic venture capital firm that partners with entrepreneurs to scale high-growth businesses, drawing on funds and networks in both the U.S. and the U.K.
Sequoia Capital is a venture capital firm that partners with founders to build technology companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
HealthQuest Capital is an investment firm focused on the healthcare sector, backing companies across areas such as medical devices, telehealth, and healthcare services.
Broadview Ventures is an impact investor focused on accelerating the development of technology for the diagnosis and treatment of cardiovascular disease and stroke through targeted investments.
▶21 more co-investors
Solas BioVenturesB Capital GroupRRE VenturesLiquid VenturesGoodwater CapitalBlockchain CapitalAltaIR CapitalDigital Currency GroupCompany CapitalAmerican Express Ventures (Amex)Accelerator VenturesFuture Perfect Ventures305 VenturesPitbull VenturesGSR VenturesNKM CapitalIGNIAJungle VenturesParallax VenturesArcus VenturesPerseverance Capital
Firms observed investing alongside Arboretum Ventures, from public investor directories. Shared companies are the overlap with Arboretum Ventures's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
CABHI (Centre for Aging + Brain Health Innovation) is a pan-Canadian organization that funds and supports researchers, innovators, and startups working on brain health and aging solutions, and helps healthcare and community organizations adopt them.